Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Fracture incidence in Ehlers-Danlos syndrome - A population-based case-control study.

Rolfes MC, Deyle DR, King KS, Hand JL, Graff AH, Derauf C.

Child Abuse Negl. 2019 May;91:95-101. doi: 10.1016/j.chiabu.2019.03.008. Epub 2019 Mar 8.

PMID:
30856599
2.

Socioeconomic Status, Race/Ethnicity, and Health Disparities in Children and Adolescents in a Mixed Rural-Urban Community-Olmsted County, Minnesota.

Bjur KA, Wi CI, Ryu E, Derauf C, Crow SS, King KS, Juhn YJ.

Mayo Clin Proc. 2019 Jan;94(1):44-53. doi: 10.1016/j.mayocp.2018.06.030.

3.

School-Aged Outcomes following Prenatal Methamphetamine Exposure: 7.5-Year Follow-Up from the Infant Development, Environment, and Lifestyle Study.

Eze N, Smith LM, LaGasse LL, Derauf C, Newman E, Arria A, Huestis MA, Della Grotta SA, Dansereau LM, Neal C, Lester BM.

J Pediatr. 2016 Mar;170:34-8.e1. doi: 10.1016/j.jpeds.2015.11.070. Epub 2016 Jan 11.

4.

Developmental and behavioral consequences of prenatal methamphetamine exposure: A review of the Infant Development, Environment, and Lifestyle (IDEAL) study.

Smith LM, Diaz S, LaGasse LL, Wouldes T, Derauf C, Newman E, Arria A, Huestis MA, Haning W, Strauss A, Della Grotta S, Dansereau LM, Neal C, Lester BM.

Neurotoxicol Teratol. 2015 Sep-Oct;51:35-44. doi: 10.1016/j.ntt.2015.07.006. Epub 2015 Jul 23. Review.

5.

Effects of prenatal methamphetamine exposure on behavioral and cognitive findings at 7.5 years of age.

Diaz SD, Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis MA, Della Grotta S, Dansereau LM, Neal C, Lester BM.

J Pediatr. 2014 Jun;164(6):1333-8. doi: 10.1016/j.jpeds.2014.01.053. Epub 2014 Mar 12.

6.

Prenatal methamphetamine exposure and neonatal and infant neurobehavioral outcome: results from the IDEAL study.

Kiblawi ZN, Smith LM, Diaz SD, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis M, Haning W, Strauss A, DellaGrotta S, Dansereau LM, Neal C, Lester B.

Subst Abus. 2014;35(1):68-73. doi: 10.1080/08897077.2013.814614.

7.

Risk of neurobehavioral disinhibition in prenatal methamphetamine-exposed young children with positive hair toxicology results.

Himes SK, LaGasse LL, Derauf C, Newman E, Smith LM, Arria AM, Della Grotta SA, Dansereau LM, Abar B, Neal CR, Lester BM, Huestis MA.

Ther Drug Monit. 2014 Aug;36(4):535-43. doi: 10.1097/FTD.0000000000000049.

8.

Cross-national comparison of prenatal methamphetamine exposure on infant and early child physical growth: a natural experiment.

Abar B, LaGasse LL, Wouldes T, Derauf C, Newman E, Shah R, Smith LM, Arria AM, Huestis MA, DellaGrotta S, Dansereau LM, Wilcox T, Neal CR, Lester BM.

Prev Sci. 2014 Oct;15(5):767-76. doi: 10.1007/s11121-013-0431-5.

9.

Cortisol reactivity in two-year-old children prenatally exposed to methamphetamine.

Kirlic N, Newman E, Lagasse LL, Derauf C, Shah R, Smith LM, Arria AM, Huestis MA, Haning W, Strauss A, Dellagrotta S, Dansereau LM, Abar B, Neal CR, Lester BM.

J Stud Alcohol Drugs. 2013 May;74(3):447-51.

10.

Prenatal methamphetamine exposure, home environment, and primary caregiver risk factors predict child behavioral problems at 5 years.

Twomey J, LaGasse L, Derauf C, Newman E, Shah R, Smith L, Arria A, Huestis M, DellaGrotta S, Roberts M, Dansereau L, Neal C, Lester B.

Am J Orthopsychiatry. 2013 Jan;83(1):64-72. doi: 10.1111/ajop.12007.

11.

The effect of prenatal methamphetamine exposure on attention as assessed by continuous performance tests: results from the Infant Development, Environment, and Lifestyle study.

Kiblawi ZN, Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis M, DellaGrotta S, Dansereau LM, Neal C, Lester B.

J Dev Behav Pediatr. 2013 Jan;34(1):31-7. doi: 10.1097/DBP.0b013e318277a1c5.

12.
13.

Examining the relationships between prenatal methamphetamine exposure, early adversity, and child neurobehavioral disinhibition.

Abar B, LaGasse LL, Derauf C, Newman E, Shah R, Smith LM, Arria A, Huestis M, Della Grotta S, Dansereau LM, Neal C, Lester BM.

Psychol Addict Behav. 2013 Sep;27(3):662-73. doi: 10.1037/a0030157. Epub 2012 Oct 15.

14.

Subcortical and cortical structural central nervous system changes and attention processing deficits in preschool-aged children with prenatal methamphetamine and tobacco exposure.

Derauf C, Lester BM, Neyzi N, Kekatpure M, Gracia L, Davis J, Kallianpur K, Efird JT, Kosofsky B.

Dev Neurosci. 2012;34(4):327-41. doi: 10.1159/000341119. Epub 2012 Aug 17.

15.

Co-morbidity of substance use disorder and psychopathology in women who use methamphetamine during pregnancy in the US and New Zealand.

Wouldes TA, LaGasse LL, Derauf C, Newman E, Shah R, Smith LM, Arria AM, Huestis MA, DellaGrotta S, Wilcox T, Neal CR Jr, Lester BM.

Drug Alcohol Depend. 2013 Jan 1;127(1-3):101-7. doi: 10.1016/j.drugalcdep.2012.06.016. Epub 2012 Jul 11.

16.

Predictors of inadequate prenatal care in methamphetamine-using mothers in New Zealand and the United States.

Wu M, Lagasse LL, Wouldes TA, Arria AM, Wilcox T, Derauf C, Newman E, Shah R, Smith LM, Neal CR, Huestis MA, Dellagrotta S, Lester BM.

Matern Child Health J. 2013 Apr;17(3):566-75. doi: 10.1007/s10995-012-1033-8.

17.

Maternal depression and prenatal exposure to methamphetamine: neurodevelopmental findings from the infant development, environment, and lifestyle (ideal) study.

Smith LM, Paz MS, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis MA, Haning W, Strauss A, Della Grotta S, Dansereau LM, Neal C, Lester BM.

Depress Anxiety. 2012 Jun;29(6):515-22. doi: 10.1002/da.21956. Epub 2012 May 3.

18.

Perceived child behavior problems, parenting stress, and maternal depressive symptoms among prenatal methamphetamine users.

Liles BD, Newman E, Lagasse LL, Derauf C, Shah R, Smith LM, Arria AM, Huestis MA, Haning W, Strauss A, Dellagrotta S, Dansereau LM, Neal C, Lester BM.

Child Psychiatry Hum Dev. 2012 Dec;43(6):943-57. doi: 10.1007/s10578-012-0305-2.

19.

Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age.

LaGasse LL, Derauf C, Smith LM, Newman E, Shah R, Neal C, Arria A, Huestis MA, DellaGrotta S, Lin H, Dansereau LM, Lester BM.

Pediatrics. 2012 Apr;129(4):681-8. doi: 10.1542/peds.2011-2209. Epub 2012 Mar 19.

20.

Prenatal methamphetamine exposure and inhibitory control among young school-age children.

Derauf C, Lagasse LL, Smith LM, Newman E, Shah R, Neal CR, Arria AM, Huestis MA, Dellagrotta S, Dansereau LM, Lin H, Lester BM.

J Pediatr. 2012 Sep;161(3):452-9. doi: 10.1016/j.jpeds.2012.02.002. Epub 2012 Mar 15.

21.

Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes.

Shah R, Diaz SD, Arria A, LaGasse LL, Derauf C, Newman E, Smith LM, Huestis MA, Haning W, Strauss A, Della Grotta S, Dansereau LM, Roberts MB, Neal C, Lester BM.

Am J Perinatol. 2012 May;29(5):391-400. doi: 10.1055/s-0032-1304818. Epub 2012 Mar 7.

22.

The effects of prenatal methamphetamine exposure on childhood growth patterns from birth to 3 years of age.

Zabaneh R, Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Dansereau LM, Lin H, Neal C, Lester BM.

Am J Perinatol. 2012 Mar;29(3):203-10. doi: 10.1055/s-0031-1285094. Epub 2011 Aug 4.

23.

Body Ideals and Body Dissatisfaction Among a Community Sample of Ethnically Diverse Adolescents on Kauai, Hawaii.

Niide TK, Davis J, Tse AM, Derauf C, Harrigan RC, Yates A.

Hawaii J Public Health. 2011 Mar;3(1):1-7.

24.

Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine.

Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Haning W, Arria A, Huestis M, Strauss A, Della Grotta S, Dansereau LM, Lin H, Lester BM.

Neurotoxicol Teratol. 2011 Jan-Feb;33(1):176-84. doi: 10.1016/j.ntt.2010.10.004.

25.

Infant temperament and high-risk environment relate to behavior problems and language in toddlers.

Derauf C, LaGasse L, Smith L, Newman E, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Dansereau L, Lin H, Lester B.

J Dev Behav Pediatr. 2011 Feb-Mar;32(2):125-35. doi: 10.1097/DBP.0b013e31820839d7.

26.

Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand.

LaGasse LL, Wouldes T, Newman E, Smith LM, Shah RZ, Derauf C, Huestis MA, Arria AM, Della Grotta S, Wilcox T, Lester BM.

Neurotoxicol Teratol. 2011 Jan-Feb;33(1):166-75. doi: 10.1016/j.ntt.2010.06.009. Epub 2010 Jul 6.

27.

Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study.

Nguyen D, Smith LM, Lagasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis MA, Haning W, Strauss A, Della Grotta S, Liu J, Lester BM.

J Pediatr. 2010 Aug;157(2):337-9. doi: 10.1016/j.jpeds.2010.04.024. Epub 2010 Jun 8.

28.

New meconium biomarkers of prenatal methamphetamine exposure increase identification of affected neonates.

Gray TR, Kelly T, LaGasse LL, Smith LM, Derauf C, Grant P, Shah R, Arria A, Haning W, Della Grotta S, Strauss A, Lester BM, Huestis MA.

Clin Chem. 2010 May;56(5):856-60. doi: 10.1373/clinchem.2009.139055. Epub 2010 Feb 25.

29.

Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study.

Gray TR, LaGasse LL, Smith LM, Derauf C, Grant P, Shah R, Arria AM, Della Grotta SA, Strauss A, Haning WF, Lester BM, Huestis MA.

Ther Drug Monit. 2009 Dec;31(6):769-75. doi: 10.1097/FTD.0b013e3181bb438e.

30.

Patterns of methamphetamine use during pregnancy: results from the Infant Development, Environment, and Lifestyle (IDEAL) Study.

Della Grotta S, LaGasse LL, Arria AM, Derauf C, Grant P, Smith LM, Shah R, Huestis M, Liu J, Lester BM.

Matern Child Health J. 2010 Jul;14(4):519-27. doi: 10.1007/s10995-009-0491-0. Epub 2009 Jun 30.

31.

Neuroimaging of children following prenatal drug exposure.

Derauf C, Kekatpure M, Neyzi N, Lester B, Kosofsky B.

Semin Cell Dev Biol. 2009 Jun;20(4):441-54. doi: 10.1016/j.semcdb.2009.03.001. Epub 2009 Mar 13. Review.

32.

Novel biomarkers of prenatal methamphetamine exposure in human meconium.

Gray TR, Kelly T, LaGasse LL, Smith LM, Derauf C, Haning W, Grant P, Shah R, Arria A, Strauss A, Lester BM, Huestis MA.

Ther Drug Monit. 2009 Feb;31(1):70-5. doi: 10.1097/FTD.0b013e318195d7cb.

33.

Maternal depression and neurobehavior in newborns prenatally exposed to methamphetamine.

Paz MS, Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Liu J, Lester BM.

Neurotoxicol Teratol. 2009 May-Jun;31(3):177-82. doi: 10.1016/j.ntt.2008.11.004. Epub 2008 Dec 3.

34.

Prenatal methamphetamine use and neonatal neurobehavioral outcome.

Smith LM, Lagasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Fallone M, Liu J, Lester BM.

Neurotoxicol Teratol. 2008 Jan-Feb;30(1):20-8. Epub 2007 Oct 3.

35.

BMI and waist circumference as indicators of health among Samoan women.

Novotny R, Nabokov V, Derauf C, Grove J, Vijayadeva V.

Obesity (Silver Spring). 2007 Aug;15(8):1913-7.

36.

Posttraumatic stress disorder and pregnancy health: preliminary update and implications.

Morland L, Goebert D, Onoye J, Frattarelli L, Derauf C, Herbst M, Matsu C, Friedman M.

Psychosomatics. 2007 Jul-Aug;48(4):304-8.

PMID:
17600166
37.

Demographic and psychosocial characteristics of mothers using methamphetamine during pregnancy: preliminary results of the infant development, environment, and lifestyle study (IDEAL).

Derauf C, LaGasse LL, Smith LM, Grant P, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Liu J, Lester BM.

Am J Drug Alcohol Abuse. 2007;33(2):281-9.

38.

The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth.

Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Liu J, Lester BM.

Pediatrics. 2006 Sep;118(3):1149-56.

PMID:
16951010
39.

Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL) study.

Arria AM, Derauf C, Lagasse LL, Grant P, Shah R, Smith L, Haning W, Huestis M, Strauss A, Della Grotta S, Liu J, Lester B.

Matern Child Health J. 2006 May;10(3):293-302. Epub 2006 Jan 5.

PMID:
16395620
40.

Smoking cessation counseling training for pediatric residents in the continuity clinic setting.

Lee MT, Hishinuma ES, Derauf C, Guerrero AP, Iwaishi LK, Kasuya RT.

Ambul Pediatr. 2004 Jul-Aug;4(4):289-94.

PMID:
15264961
42.

Preventive health counselling for paediatric residents.

Lee MT, Derauf C, Kasuya RT.

Med Educ. 2002 Nov;36(11):1107-8. No abstract available.

PMID:
12406298
43.

Shaken baby syndrome--a forensic pediatric response.

Chadwick DL, Kirschner RH, Reece RM, Ricci LR, Alexander R, Amaya M, Bays JA, Bechtel K, Beltran-Coker R, Berkowitz CD, Blatt SD, Botash AS, Brown J, Carrasco M, Christian C, Clyne P, Coury DL, Crawford J, Cunningham N, DeBellis MD, Derauf C, de Triquet J, Dreyer BP, Dubowitz H, Zenel JA Jr, et al.

Pediatrics. 1998 Feb;101(2):321-3. No abstract available.

PMID:
9457163

Supplemental Content

Loading ...
Support Center